Pfizer Inc. (NYSE:PFE), the Canadian distributor of EpiPen® (epinephrine) Auto‐Injector is proud to announce its entry in the 2014 NASCAR Canadian Tire Series as the title sponsor of Alex Tagliani’s No. 18 car. “Pfizer is pleased to be entering the NASCAR Canadian Tire Series as Alex Tagliani’s title sponsor,” said Allen Van Der Wee, General Manager, Global Established Products Business Unit at Pfizer Canada Inc. “We are looking forward to partnering with Alex for a second year to raise awareness for food allergies and anaphylaxis management.” Pfizer Inc. (NYSE:PFE) stock opened at $30.84 in last trading session, and closed at $31.22, trading in the range of $30.61 -$ 31.28. The stock showed a positive weekly performance of 3.55%.
Gilead Sciences (NASDAQ:GILD) had its price objective hosited by RBC Capital from $90.00 to $96.00 in a report released on Wednesday, American Banking & Market News reports. RBC Capital currently has an outperform rating on the stock. Gilead Sciences, Inc. (NASDAQ:GILD) shares closed at $78.75 on last trade day, by gaining 2.94%. Stock 52 week range is $39.48 – $84.40. Company’s market capitalization is $120.84 billion.
Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 2014 Leerink Global Healthcare Conference. The presentation will take place on Wednesday, February 12, 2014 at 3:55 p.m. ET at the Waldorf Astoria Hotel in New York, New York. Galena Biopharma Inc (NASDAQ:GALE) stock advanced 15.46% and finished the last session at $4.93. The EPS of the stock remained -0.38. Company’s market capitalization is $518.82 billion.
Merck & Co (NYSE:MRK) had its price target increased by JPMorgan Chase & Co. from $55.00 to $60.00 in a research report sent to investors on Thursday morning, AmericanBankingNews.com reports. Merck & Co., Inc. (NYSE:MRK) stock opened at $53.65 in last trading session and closed at $54.77. The 52 week range of the stock is $40.83 – $55.20 and the day range was $53.44 – $54.82.